David B Solit


Ontology type: schema:Person     


Person Info

NAME

David B

SURNAME

Solit

Publications in SciGraph latest 50 shown

  • 2019-03 Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer in GASTRIC CANCER
  • 2019-02 Tumor mutational load predicts survival after immunotherapy across multiple cancer types in NATURE GENETICS
  • 2018-09 Clinical tumour sequencing for precision oncology: time for a universal strategy in NATURE REVIEWS CANCER
  • 2018-08 Genome doubling shapes the evolution and prognosis of advanced cancers in NATURE GENETICS
  • 2018-07 Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2018-02 HER kinase inhibition in patients with HER2- and HER3-mutant cancers in NATURE
  • 2017-12 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets in GENOME MEDICINE
  • 2017-12 A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer in BREAST CANCER RESEARCH
  • 2017-08 Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS in NATURE
  • 2017-06 Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients in NATURE MEDICINE
  • 2016-04 Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer in NATURE GENETICS
  • 2016-02 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity in NATURE BIOTECHNOLOGY
  • 2015-02 Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor in NATURE
  • 2014-08 Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions in GENOME BIOLOGY
  • 2013-11 Tumor adaptation and resistance to RAF inhibitors in NATURE MEDICINE
  • 2013-03 Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation in NATURE GENETICS
  • 2012-10 Targeted next-generation sequencing of colorectal cancer identified metastatic specific genetic alterations in BMC PROCEEDINGS
  • 2012-08 Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2012-07 Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion in NATURE
  • 2012-07 Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-06 Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer in NATURE
  • 2012-04 A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-03 Translational medicine: Primed for resistance in NATURE
  • 2012-01 Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF in ONCOGENE
  • 2011-12 RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) in NATURE
  • 2011-12 The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both? in CURRENT ONCOLOGY REPORTS
  • 2011-10 Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion in NATURE GENETICS
  • 2011-08-05 Targeting Oncogenic BRAF in Human Cancer in THERAPEUTIC KINASE INHIBITORS
  • 2010-12 Drug discovery: How melanomas bypass new therapy in NATURE
  • 2010-10 Tracing cancer networks with phosphoproteomics in NATURE BIOTECHNOLOGY
  • 2010-01 Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth in ONCOGENE
  • 2010-01 Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies in NATURE GENETICS
  • 2008-01 Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo in NATURE BIOTECHNOLOGY
  • 2007-12 A polyvalent vaccine for high-risk prostate patients: “are more antigens better?” in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2007-03 A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2006-01 BRAF mutation predicts sensitivity to MEK inhibition in NATURE
  • 2004-06 Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors in NATURE BIOTECHNOLOGY
  • 2002-02 Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2 in ONCOGENE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.51462.34", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21107.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240614.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.134563.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.47100.32", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.19006.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.283529.7", 
            "type": "Organization"
          }
        ], 
        "familyName": "Solit", 
        "givenName": "David B", 
        "id": "sg:person.0656335277.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656335277.50"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:52", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_589.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0656335277.50'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0656335277.50'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0656335277.50'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0656335277.50'


     

    This table displays all metadata directly associated to this object as RDF triples.

    32 TRIPLES      10 PREDICATES      19 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0656335277.50 schema:affiliation N927098772e3b46c5a04b95a1597b50f2
    2 https://www.grid.ac/institutes/grid.134563.6
    3 https://www.grid.ac/institutes/grid.19006.3e
    4 https://www.grid.ac/institutes/grid.21107.35
    5 https://www.grid.ac/institutes/grid.240614.5
    6 https://www.grid.ac/institutes/grid.283529.7
    7 https://www.grid.ac/institutes/grid.47100.32
    8 https://www.grid.ac/institutes/grid.5386.8
    9 https://www.grid.ac/institutes/grid.65499.37
    10 schema:familyName Solit
    11 schema:givenName David B
    12 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656335277.50
    13 schema:sdDatePublished 2019-03-07T14:52
    14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    15 schema:sdPublisher Nf7425f8d9b654bf4991d3e2c142b8d44
    16 sgo:license sg:explorer/license/
    17 sgo:sdDataset persons
    18 rdf:type schema:Person
    19 N927098772e3b46c5a04b95a1597b50f2 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
    20 sgo:isCurrent true
    21 rdf:type schema:OrganizationRole
    22 Nf7425f8d9b654bf4991d3e2c142b8d44 schema:name Springer Nature - SN SciGraph project
    23 rdf:type schema:Organization
    24 https://www.grid.ac/institutes/grid.134563.6 schema:Organization
    25 https://www.grid.ac/institutes/grid.19006.3e schema:Organization
    26 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    27 https://www.grid.ac/institutes/grid.240614.5 schema:Organization
    28 https://www.grid.ac/institutes/grid.283529.7 schema:Organization
    29 https://www.grid.ac/institutes/grid.47100.32 schema:Organization
    30 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    31 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
    32 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...